Anaemia in rheumatoid arthritis: Can we afford to ignore it?

Postgraduate Medical Journal

Volumn 87, Issue 1031, 2011, Pages 596-600

  Bloxham, E ^a   Vagadia, V ^a   Scott, K ^a   Francis, G ^a   Saravanan, V ^a   Heycock, C ^a   Rynne, M ^a   Hamilton, J ^a   Kelly, C A ^a  

^a QUEEN ELIZABETH HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

DISEASE MODIFYING ANTIRHEUMATIC DRUG; ERYTHROPOIETIN; HEMOGLOBIN; METHOTREXATE; SALAZOSULFAPYRIDINE;

ALCOHOLISM; ANEMIA; ARTICLE; BLOOD CELL COUNT; CYANOCOBALAMIN DEFICIENCY; DRUG EFFICACY; DRUG SAFETY; ERYTHROCYTE SEDIMENTATION RATE; GASTROINTESTINAL HEMORRHAGE; HEMATURIA; HUMAN; HYPOTHYROIDISM; IRON DEFICIENCY ANEMIA; MACROCYTIC ANEMIA; MAJOR CLINICAL STUDY; RHEUMATOID ARTHRITIS; TREATMENT RESPONSE; VAGINA BLEEDING;

ANEMIA; ANEMIA, IRON-DEFICIENCY; ANEMIA, MACROCYTIC; ARTHRITIS, RHEUMATOID; CHRONIC DISEASE; COHORT STUDIES; COSTS AND COST ANALYSIS; FERRITINS; HUMANS; NEOPLASMS;

EID: 80052051025     PISSN: 00325473     EISSN: 14690756     Source Type: Journal    
DOI: 10.1136/pgmj.2011.117507     Document Type: Article

References (44)

1. Rajapakse CN, Holt PJ, Perera B. Diagnosis of true iron deficiency in rheumatoid arthritis. Ann Rheum Dis 1980;39:596-8.
2. Hansen TM, Hansen NE, Birgens HS, et al. Serum ferritin and the assessment of iron deficiency in rheumatoid arthritis. Scand J Rheumatol 1983;12:353-9.
3. Wilson A, Yu HT, Goodnough LT, et al. Prevalence and outcomes of anemia in rheumatoid arthritis: a systematic review of the literature. Am J Med 2004;116:50S-70S.
4. Pincus T, O'Dell JR, Kremer JM. Combination therapy with multiple diseasemodifying antirheumatic drugs in rheumatoid arthritis: a preventive strategy. Ann Intern Med 1999;131:768-74.
5. Kay J, Bryant S, Cravets MW, et al. IL-1 receptor antagonist (IL-1ra) treatment is associated with improvement of anaemia in rheumatoid arthritis. Ann Rheum Dis 2001;60:152-3.
6. Vreugdenhil G, Baltus CA, van Eijk HG, et al. Anaemia of chronic disease: diagnostic significance of erythrocyte and serological parameters in iron deficient rheumatoid arthritis patients. Br J Rheumatol 1990;29:105-10.
7. Baer AN, Dessypris EN, Goldwasser E, et al. Blunted erythropoietin response to anaemia in rheumatoid arthritis. Br J Haematol 1987;66:559-64.
8. Hochberg MC, Arnold CM, Hogans BB, et al. Serum immunoreactive erythropoietin in rheumatoid arthritis: impaired response to anemia. Arthritis Rheum 1988;31:1318-21.
9. Maury CP. Anaemia in rheumatoid arthritis: role of cytokines. Scand J Rheumatol 1989;18:3-5.
10. Voulgari PV, Kolios G, Papadopoulos GK, et al. Role of cytokines in the pathogenesis of anaemia of chronic disease in rheumatoid arthritis. Clin Immunol 1999;92:153-60.
11. Means RT Jr. Advances in the anemia of chronic disease. Int J Hematol 1999;70:7-12.
12. Swaak A. Anaemia of chronic disease in patients with rheumatoid arthritis: aspects of prevalence, outcome, diagnosis, and the effect of treatment on disease activity. J Rheumatol 2006;33:1467-9.
13. Porter DR, Sturrock RD, Capell HA. The use of serum ferritin estimation in the investigation of anaemia in patients with rheumatoid arthritis. Clin Exp Rheumatol 1994;12:179-82.
14. Vreugdenhil G, Swaak AJ. Anaemia in rheumatoid arthritis: pathogenesis, diagnosis and treatment. Rheumatol Int 1990;9:243-57.
15. Peeters HR, Jongen-Lavrencic M, Raja AN, et al. Course and characteristics of anaemia in patients with rheumatoid arthritis of recent onset. Ann Rheum Dis 1996;55:162-8.
16. Blake DR, Waterworth RF, Bacon PA. Assessment of iron stores in inflammation by assay of serum ferritin concentrations. Br Med J (Clin Res Ed) 1981;283:1147-8.
17. Baynes RD, Bothwell TH, Bezwoda WR, et al. Hematologic and iron-related measurements in rheumatoid arthritis. Am J Clin Pathol 1987;87:196-8.
18. Baer AN, Dessypris EN, Krantz SB. The pathogenesis of anaemia in rheumatoid arthritis: a clinical and laboratory analysis. Semin Arthritis Rheum 1990;19:209-12.
19. Mulherin D, Skelly M, Saunders A, et al. The diagnosis of iron deficiency in patients with rheumatoid arthritis and anemia: an algorithm using simple laboratory measures. J Rheumatol 1996;23:237-40.
20. Doube A, Davis M, Smith JG, et al. Structured approach to the investigation of anaemia in patients with rheumatoid arthritis. Ann Rheum Dis 1992;51:469-72.
21. Fitzsimons EJ, Houston T, Munro R, et al. Erythroblast iron metabolism and serum soluble transferrin receptor values in the anemia of rheumatoid arthritis. Arthritis Rheum 2002;47:166-9.
22. Baillie FJ, Morrison AE, Fergus I. Soluble transferrin receptor: a discriminating assay for iron deficiency. Clin Lab Haematol 2003;25:353-6.
23. Vreugdenhil G, Wognum AW, van Eijk HG, et al. Anaemia in rheumatoid arthritis: the role of iron, vitamin B12, and folic acid deficiency, and erythropoietin responsiveness. Ann Rheum Dis 1990;49:93-8.
24. Partridge RE, Duthie JJ. Incidence of macrocytic anaemia in rheumatoid arthritis. Br Med J 1963;1:89-91.
25. Luqmani R, Hennell S, Estrach C, et al. British Society for Rheumatology and British Health Professionals in Rheumatology Guideline for the Management of Rheumatoid Arthritis (The first 2 years). Rheumatology (Oxford) 2006;45:1167-9.
26. Arnett FC, Edworthy SM, Bloch DA, et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988;31:315-24.
27. Goddard AF, James MW, McIntyre AS, et al; on behalf of the BSG. Guidelines for the management of iron deficiency anaemia, 2005. http://www.bsg.org.uk.
28. Repping-Wuts H, van Riel P, van Achterberg T. Fatigue in patients with rheumatoid arthritis: what is known and what is needed. Rheumatology 2009;48:207-9.
29. Cimmino MA, Parisi M, Querci G, et al. Intravenous iron is effective in treating the anaemia of rheumatoid arthritis and is not associated with flares of synovitis. Clin Rheumatol 1997;16:215-16.
30. Nielsen OJ, Andersen LS, Ludwigsen E, et al. Anaemia of rheumatoid arthritis: serum erythropoietin concentrations and red cell distribution width in relation to iron status. Ann Rheum Dis 1990;49:349-53.
31. Matsuda S, Kondo M, Mashima T, et al. Recombinant human erythropoietin therapy for autologous blood donation in rheumatoid arthritis patients undergoing total hip or knee arthroplasty. Orthopedics 2001;24:41-4.
32. Matsui H, Shiraishi N, Yasuda T, et al. The effects of recombinant human erythropoietin on autologous blood donation in rheumatoid arthritis patients with anaemia. Clin Exp Rheumatol 1999;17:69-74.
33. Sowade O, Warnke H, Scigalla P, et al. Avoidance of allogeneic blood transfusions by treatment with epoetin beta (recombinant human erythropoietin) in patients undergoing open heart surgery. Blood 1997;89:411-18.
34. Bourantas KL, Xenakis TA, Hatzimichael EC, et al. Peri-operative use of recombinant human erythropoietin in Jehovah's Witnesses. Haematologica 2000;85:444-5.
35. Means RT Jr, Olsen NJ, Krantz SB, et al. Treatment of the anemia of rheumatoid arthritis with recombinant human erythropoietin: clinical and in vitro studies. Arthritis Rheum 1989;32:638-42.
36. Pincus T, Olsen NJ, Russell IJ, et al. Multicenter study of recombinant human erythropoietin in correction of anemia in rheumatoid arthritis. Am J Med 1990;89:161-8.
37. Fantini F, Gattinara M, Gerloni V, et al. Severe anemia associated with active systemic-onset juvenile rheumatoid arthritis successfully treated with recombinant human erythropoietin: a pilot study. Arthritis Rheum 1992;35:724-6.
38. Pettersson T, Rosenlof K, Laitinen E, et al. Effect of exogenous erythropoietin on haem synthesis in anaemic patients with rheumatoid arthritis. Br J Rheumatol 1994;33:526-9.
39. Peeters HR, Jongen-Lavrencic M, Vreugdenhil G, et al. Effect of recombinant human erythropoietin on anaemia and disease activity in patients with rheumatoid arthritis and anaemia of chronic disease: a randomised placebo controlled double blind 52 weeks clinical trial. Ann Rheum Dis 1996;55:739-44.
40. Peeters HR, Jongen-Lavrencic M, Bakker CH, et al. Recombinant human erythropoietin improves health-related quality of life in patients with rheumatoid arthritis and anaemia of chronic disease: utility measures correlate strongly with disease activity measures. Rheumatol Int 1999;18:201-6.
41. Kaltwasser JP, Kessler U, Gottschalk R, et al. Effect of recombinant human erythropoietin and intravenous iron on anemia and disease activity in rheumatoid arthritis. J Rheumatol 2001;28:2430-6.
42. Shiroky JB, Cohen M, Ballachey ML, et al. Thyroid dysfunction in rheumatoid arthritis: a controlled prospective survey. Ann Rheum Dis 1993;52:454-6.
43. Gridley G, McLaughlin JK, Ekbom A, et al. Incidence of cancer among patients with rheumatoid arthritis. J Natl Cancer Inst 1993;85:307-11.
44. Luqmani R, Hennell S, Estrach C, et al. British Society for Rheumatology and British Health Professionals in Rheumatology guideline for the management of rheumatoid arthritis (after the first 2 years) Rheumatology 2009;48:1-23.